Radiance Biopharma Showcases First‑in‑Class c‑MET/EGFR Bispecific Nano ADC at Leading Global ADC Conference
Introduction of a Differentiated Bispecific Nano ADC Positioned to Compete in Major Global Oncology Markets BOSTON, MA, UNITED STATES, February 20, 2026 /EINPresswire.com/ -- Radiance Biopharma announced today that Chief Executive Officer Robert …